Product Images Emtricitabine And Tenofovir Disoproxil Fumarate

This is a description of medication with the National Drug Code (NDC) 68180-287-06, which is a combination of Emtricitabine and Tenofovir Disoproxil Fumarate tablets. It is indicated for prescription use only and should be dispensed with a medication guide to the patient by the pharmacist. Each film-coated tablet contains emtricitabine 200mg and tenofovir disoproxil fumarate 245mg (equivalent to 300mg of tenofovir disoproxil). The usual dosage is provided in the accompanying prescribing information. The medication should be stored within a specific temperature range, and the container must be tightly closed and dispensed only in the original container. For more information, visit the Lupin website or scan the QR code provided. The medication is manufactured by Lupin Pharmaceuticals, Inc. in Baltimore, Maryland, for distribution in the United States.*

This text provides information about a medication with the NDC code 68180-287-01, which contains Emtricitabine and Tenofovir Disoproxil Fumarate Tablets and has a dosage of 200mg and 300mg. The tablets are film-coated and stored at a temperature between 15-30°C (59-85°F). The medication guide can be found on the website www.lpin.com/emiriabin-tab-mo.pe. The manufacturer of the medication is Lupin Limited located in Nagpur, India. The code number is MHDRUGS/25-ND/59. The text also states that the medication should be dispensed with a medication guide to each patient by the pharmacist.*